Fulltext present in this item

Thumbnail
Fulltext: 97908.pdf
Format: PDF
Description: publisher's version
Embargo: until further notice
Title: F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis
Author(s): Rooy, J.W.J. de ; Hambrock, T. ; Vriens, D. ; Flucke, U.E. ; Geest, I.C.M. van der ; Luijtgaarden, A.C.M. van de ; Schreuder, B. ; Geus-Oei, L.F. de
Publication year: 2011
Source: Clinical Nuclear Medicine, vol. 36, iss. 7, (2011), pp. 565-567
ISSN: 0363-9762
DOI: https://doi.org/10.1097/RLU.0b013e318217561c
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/97908   https://hdl.handle.net/2066/97908

Display more details
Subject: ONCOL 3: Translational research
ONCOL 4: Quality of Care
ONCOL 5: Aetiology, screening and detection
Organization: Radiology
Nuclear Medicine
Pathology
Orthopaedics
Medical Oncology
Journal title:
Clinical Nuclear Medicine
Volume: vol. 36
Issue: iss. 7
Page start: p. 565
Page end: p. 567
Abstract:
Ten years after chemoradiation for primary lymphoma of the left pelvic bone, a 38-year-old man presented with a 4-month history of gradually increasing pain in his left upper leg and thigh. Initial radiographs and contrast-enhanced magnetic resonance imaging were consistent with recurrent lymphoma, infection, or postirradiation sarcoma. Subsequent F-18 fluorodeoxyglucose positron emission tomography/computed tomography demonstrated a focal area of F-18 fluorodeoxyglucose-avidity within the previously irradiated bone consistent with tumor and the location was confirmed by advanced magnetic resonance imaging techniques and histopathology, thus optimizing treatment planning.

This item appears in the following Collection(s)

Browse

Statistics